CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma

Gregory M. Hayes, Belinda Cairns, Zoia Levashova, Lawrence Chinn, Myra Perez, Jan Willem Theunissen, Sindy Liao-Chan, Abel Bermudez, Mark R. Flory, Karl J. Schweighofer, Edward H. van der Horst

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences